P13760 (2B14_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 131.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: HLA class II histocompatibility antigen, DRB1-4 beta chain Alternative name(s): MHC class II antigen DRB1*4 Short name=DR-4 Short name=DR4 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 266 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route; where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules; and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments; exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides; autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs; other cells of the gastrointestinal tract; such as epithelial cells; express MHC class II molecules and CD74 and act as APCs; which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen; three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs; CD74 undergoes a sequential degradation by various proteases; including CTSS and CTSL; leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells; the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the regulation of antigen loading into MHC II molecules; increased acidification produces increased proteolysis and efficient peptide loading. |
| Subunit structure | Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmic reticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariant chain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoes sequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHC class II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding of antigenic peptides. |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus › trans-Golgi network membrane; Single-pass type I membrane protein. Endosome membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosome membrane; Single-pass type I membrane protein. Note: The MHC class II complex transits through a number of intracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation. Ref.18 |
| Post-translational modification | Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to sorting into the endosome system and down-regulation of MHC class II Probable. Ref.18 |
| Polymorphism | The following alleles of DRB1-4 are known: DRB1*04:01, DRB1*04:02, DRB1*04:03, DRB1*04:04, DRB1*04:05, DRB1*04:06, DRB1*04:07, DRB1*04:08, DRB1*04:09, DRB1*04:10, DRB1*04:11, DRB1*04:12, DRB1*04:13, DRB1*04:14, DRB1*04:15, DRB1*04:16, DRB1*04:17, DRB1*04:18, DRB1*04:19, DRB1*04:20, DRB1*04:21, DRB1*04:22, DRB1*04:23, DRB1*04:24, DRB1*04:25, DRB1*04:26, DRB1*04:27, DRB1*04:28, DRB1*04:29, DRB1*04:30, DRB1*04:31, DRB1*04:32, DRB1*04:33, DRB1*04:34, DRB1*04:35, DRB1*04:36, DRB1*04:37, DRB1*04:38, DRB1*04:39, DRB1*04:40, DRB1*04:41, DRB1*04:42, DRB1*04:43, DRB1*04:44, DRB1*04:45, DRB1*04:46, DRB1*04:47, DRB1*04:48, DRB1*04:49, DRB1*04:50, DRB1*04:51, DRB1*04:52, DRB1*04:53, DRB1*04:54, DRB1*04:55, DRB1*04:56, DRB1*04:57, DRB1*04:58, DRB1*04:59, DRB1*04:60, DRB1*04:61, DRB1*04:62, DRB1*04:63, DRB1*04:64, DRB1*04:65, DRB1*04:66, DRB1*04:67, DRB1*04:68, DRB1*04:69, DRB1*04:70, DRB1*04:71, DRB1*04:72, DRB1*04:73, DRB1*04:74, DRB1*04:75, DRB1*04:76, DRB1*04:77 and DRB1*04:78. The sequence shown is that of DRB1*04:01. |
| Sequence similarities | Belongs to the MHC class II family. Contains 1 Ig-like C1-type (immunoglobulin-like) domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 29 | 29 | ||||||||||||||||||||||||||||||||||||||||||||
| Chain | 30 – 266 | 237 | HLA class II histocompatibility antigen, DRB1-4 beta chain | PRO_0000018950 | ||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 30 – 227 | 198 | Extracellular Potential | |||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 228 – 250 | 23 | Helical; Potential | |||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 251 – 266 | 16 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||
| Domain | 126 – 214 | 89 | Ig-like C1-type | |||||||||||||||||||||||||||||||||||||||||||
| Region | 30 – 124 | 95 | Beta-1 | |||||||||||||||||||||||||||||||||||||||||||
| Region | 125 – 227 | 103 | Beta-2 | |||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 48 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 44 ↔ 108 | By similarity | ||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 146 ↔ 202 | By similarity | ||||||||||||||||||||||||||||||||||||||||||||
| Cross-link | 254 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | ||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 5 | 1 | K → R. Corresponds to variant rs9270305 [ dbSNP | Ensembl ]. | VAR_056529 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 86 | 1 | D → S in allele DRB1*04:11; requires 2 nucleotide substitutions. | VAR_016673 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 96 | 1 | L → I in allele DRB1*04:02. | VAR_016674 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 99 | 1 | Q → D in allele DRB1*04:02; requires 2 nucleotide substitutions. | VAR_016675 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 100 | 1 | K → E in allele DRB1*04:02. | VAR_016676 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 100 | 1 | K → R in allele DRB1*04:03, allele DRB1*04:04 and allele DRB1*04:11. | VAR_016677 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 103 | 1 | A → E in allele DRB1*04:03 and allele DRB1*04:11. | VAR_016678 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 115 | 1 | G → V in allele DRB1*04:02, allele DRB1*04:03, allele DRB1*04:04 and allele DRB1*04:11. | VAR_016679 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 236 | 1 | V → M. Corresponds to variant rs2230816 [ dbSNP | Ensembl ]. | VAR_056530 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 262 | 1 | T → R. Corresponds to variant rs9269744 [ dbSNP | Ensembl ]. | VAR_056531 | ||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 154 | 1 | G → A in AAA59805. Ref.4 | |||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 36 – 47 | 12 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 48 – 51 | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 52 – 61 | 10 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 64 – 70 | 7 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 71 – 73 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 75 – 80 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 81 – 83 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 84 – 91 | 8 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 94 – 101 | 8 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 103 – 106 | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 108 – 115 | 8 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 116 – 118 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 119 – 121 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 127 – 132 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 143 – 154 | 12 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 157 – 162 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 165 – 167 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 169 – 173 | 5 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 180 – 182 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 184 – 191 | 8 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 199 – 205 | 7 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 213 – 218 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Class II genes of the human major histocompatibility complex. Organization and evolutionary relationship of the DR beta genes." Andersson G., Larhammar D., Widmark E., Servenius B., Peterson P.A., Rask L. J. Biol. Chem. 262:8748-8758(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DRB1*04:01). |
| [2] | Erratum Andersson G., Larhammar D., Widmark E., Servenius B., Peterson P.A., Rask L. J. Biol. Chem. 263:8551-8551(1988) Cited for: SEQUENCE REVISION. |
| [3] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE DRB1*04:01). |
| [4] | "Allelic variation in the DR subregion of the human major histocompatibility complex." Bell J.I., Denney D. Jr., Foster L., Belt T.K., Todd J.A., McDevitt H.O. Proc. Natl. Acad. Sci. U.S.A. 84:6234-6238(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 30-266 (ALLELE DRB1*04:01). |
| [5] | "Structural organization of the DR subregion of the human major histocompatibility complex." Spies T., Sorrentino R., Boss J.M., Okada K., Strominger J.L. Proc. Natl. Acad. Sci. U.S.A. 82:5165-5169(1985) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*04:01). |
| [6] | "A new silent mutation at codon 35 in exon 2 yielding a DRB1*04012 allele." Thonnard J., Gervais T., Heusterpreute M., Mersch G., De Canck I., De Greef C., Demanet C., Van Waeyenberge C. Tissue Antigens 49:274-276(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*04:01). |
| [7] | "Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles." Ramon D., Corell A., Cox S.T., Soteriou B., Madrigal J.A., Marsh S.G.E. Eur. J. Immunogenet. 29:453-455(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*04:02). |
| [8] | "HLA class II polymorphism." Arnaiz-Villena A. Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 43-115 (ALLELE DRB1*04:03). Tissue: Blood. |
| [9] | "New HLA class II (DRB1) alleles detected by sequencing-based typing." Greville W.D., van Eijck A., Dunckley H. Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 37-122 (ALLELE DRB1*04:03). |
| [10] | "Confirmatory sequence of HLA-DRB1*04032." Guttridge M.G., Hammond L. Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-123 (ALLELE DRB1*04:03). |
| [11] | "Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants." Cairns J.S., Curtsinger J.M., Dahl C.A., Freeman S., Alter B.J., Bach F.H. Nature 317:166-168(1985) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*04:04). |
| [12] | "Molecular diversity of HLA-DR4 haplotypes." Gregersen P.K., Shen M., Song Q.-L., Merryman P., Degar S., Seki T., Maccari J., Goldberg D., Murphy H., Schwenzer J., Wang C.Y., Winchester R.J., Nepom G.T., Silver J. Proc. Natl. Acad. Sci. U.S.A. 83:2642-2646(1986) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 30-123 (ALLELE DRB1*04:04). |
| [13] | "Full cDNA sequence of HLA-DRB1*0411." Zhao W., Fernandez-Vina M.A., Stastny P. Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRB1*04:11). |
| [14] | "Invariant chain structure and MHC class II function." Cresswell P. Cell 84:505-507(1996) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [15] | "Presentation of antigens by MHC class II molecules: getting the most out of them." Villadangos J.A. Mol. Immunol. 38:329-346(2001) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [16] | "Autophagy in MHC class II presentation: sampling from within." Menendez-Benito V., Neefjes J. Immunity 26:1-3(2007) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [17] | "MHC class II molecules on the move for successful antigen presentation." Rocha N., Neefjes J. EMBO J. 27:1-5(2008) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [18] | "MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation." De Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N., Pierre P., Gatti E. Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION BY MARCH1, SUBCELLULAR LOCATION. |
| [19] | "MHC class II transport at a glance." Berger A.C., Roche P.A. J. Cell Sci. 122:1-4(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [20] | "CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract." Beswick E.J., Reyes V.E. World J. Gastroenterol. 15:2855-2861(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [21] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [22] | "X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II." Dessen A., Lawrence C.M., Cupo S., Zaller D.M., Wiley D.C. Immunity 7:473-481(1997) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF COMPLEX WITH A COLLAGEN PEPTIDE. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M20548 Genomic DNA. No translation available. M20549 Genomic DNA. No translation available. M20550 Genomic DNA. No translation available. AL137064 Genomic DNA. Translation: CAC19360.1. M17381 mRNA. Translation: AAA59805.1. K02776 Genomic DNA. Translation: AAA59808.1. X96851 Genomic DNA. No translation available. AJ297586 mRNA. Translation: CAC08826.2. AF029269 Genomic DNA. Translation: AAF65479.1. AF112876 Genomic DNA. Translation: AAD29581.1. AJ295845 Genomic DNA. Translation: CAC08181.1. X02902 mRNA. Translation: CAA26660.1. M15069 mRNA. Translation: AAA59809.1. L42143 mRNA. Translation: AAA67104.1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPI | IPI00887633. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PIR | A29310. A94681. I79419. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UniGene | Hs.534322. Hs.696211. Hs.716081. Hs.723344. Hs.736560. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IntAct | P13760. 6 interactions. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhosphoSite | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DMDM | 122253. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PaxDb | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PRIDE | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000419393; ENSP00000403458; ENSG00000228080. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GeneCards | GC06M032546. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| H-InvDB | HIX0207659. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:4948. HLA-DRB1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MIM | 142857. gene. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| neXtProt | NX_P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| eggNOG | NOG68200. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG012730. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InParanoid | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG461454. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhylomeDB | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reactome | REACT_6900. Immune System. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ArrayExpress | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CleanEx | HS_HLA-DRB1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Genevestigator | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000196126. Homo sapiens. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gene3D | 2.60.40.10. 1 hit. 3.10.320.10. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003006. Ig/MHC_CS. IPR003597. Ig_C1-set. IPR011162. MHC_I/II-like_Ag-recog. IPR014745. MHC_II_a/b_N. IPR000353. MHC_II_b_N. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF07654. C1-set. 1 hit. PF00969. MHC_II_beta. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProDom | PD000328. MHC_II_b_N. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SMART | SM00407. IGc1. 1 hit. SM00921. MHC_II_beta. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF54452. MHC_I/II-like_Ag-recog. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS50835. IG_LIKE. 1 hit. PS00290. IG_MHC. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ChiTaRS | HLA-DRB1. human. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | P13760. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | 2B14_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P13760 Secondary accession number(s): O19717 Q9XRY5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
